🇺🇸 FDA
Pipeline program

Shigella sonnei 53G

CVIA 088

Phase 1 mab active

Quick answer

Shigella sonnei 53G for Shigellosis is a Phase 1 program (mab) at UNITED THERAPEUTICS Corp with 2 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Shigellosis
Phase
Phase 1
Modality
mab
Status
active

Clinical trials